Search results for: 'partnering agreements weill alexion pharmaceutical 2016 2016'
- Related search terms
- partnering agreements with busi 221b 2017
- partnering agreements with busi 2016 2017
- partnering agreements with the medicine compani 2024 2024
- partnering agreements with busi 2016 2025
- partnering agreements with busi 2025 2025
-
Joint Venture Deals in Pharmaceuticals and Biotechnology 2016-2025April 2025$3,995.00Track JV activity across pharma and biotech with real-world examples, financial terms, and partnering trends—includes access to contract documents where available.
Learn More -
Asset Purchase Deals in Pharmaceuticals and Biotechnology 2019 to 2025March 2025$3,995.00Asset Purchase Deals in Pharmaceuticals and Biotechnology | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Comprehensive deal directory 2019 to 2025
Learn More -
Royalty Rates in Pharmaceutical and Biotechnology Deals 2010 to 2025July 2025$3,995.00Essential Benchmark Data for Dealmakers | Global coverage | Updated to 2025 | 15+ years of royalty rates | Deal financials | Contract documents | Royalty rate trends
Learn More -
Vaccine Collaboration and Licensing Deals 2016-2025May 2025$3,995.00Vaccine Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2016 to 2025
Learn More -
Infectious Vaccine Collaboration and Licensing Deals 2016-2025May 2025$3,995.00Infectious Vaccine Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2016 to 2025
Learn More -
Autoimmune Collaboration and Licensing Deals 2016-2025April 2025$3,995.00Autoimmune Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2016 to 2025
Learn More -
Option and Evaluation Deals in Pharmaceuticals and Biotechnology 2019-2025March 2025$3,995.00Option and Evaluation Deals in Pharmaceuticals and Biotechnology | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Comprehensive deal directory 2019 to 2025
Learn More -
Licensing Deals in Pharmaceuticals 2019-2025July 2025$4,995.00Licensing Deals in Pharmaceuticals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Comprehensive deal directory 2019 to 2025
Learn More -
Cardiovascular Collaboration and Licensing Deals 2016-2025April 2025$3,995.00Cardiovascular Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2016 to 2025
Learn More -
Musculoskeletal Collaboration and Licensing Deals 2016-2025April 2025$3,995.00Musculoskeletal Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals | Comprehensive deal directory 2016 to 2025
Learn More
